# Junxiu

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/junxiu

- Industry: Medical Devices & Equipment
- Headquarters: Yantai, China
- Website: www.ytjunxiu.com
- Total disclosed funding: $6.3M
- Latest round: Series B (Oct 19, 2022)
- Investors on record: 3

## About

Established in 2012 and based in Yantai, China, Junxiu operates as a medical devices developer that focuses on implantable medical devices R&D. The company listed on the new third board in 2016 and the stock code is 839761. In 2017, the company's R&D center was recognized as Yantai medical materials engineering laboratory for human tissue reconstruction. In 2017, Junxiu invested to establish laboratory animal center, including pharmacology, pathology and toxicology testing. Junxiu cooperates with Shandong Academy of Sciences, Shandong Academy of Medical Sciences, Binzhou Medical College, Shenyang Pharmaceutical University.

The company provides class III implanted medical devices such as nerve repair catheter, nerve repair membrane and medical chitosan. And it adopts natural biological materials, polymer materials and tissue engineering materials for expression in vitro. Its laboratory's instruments include gas phase, liquid phase, gas quality, liquid quality and atomic absorption. The company's products can apply in orthopedics, neurosurgery, otorhinolaryngology, dermatology and plastic surgery.

## Funding rounds

- Series B, Oct 19, 2022, $6.3M — Shenzhen Capital Real Estate Fund, Qianhai Ark Capital, Qingdao Huatong Venture Capital

## Investors

- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series B
- Qianhai Ark Capital (https://capitalatlas.ai/funds/qianhai-ark-capital) — Series B
- Qingdao Huatong Venture Capital — Series B